Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen:
doi:10.22028/D291-43987
Dateien zu diesem Datensatz:
Datei | Beschreibung | Größe | Format | |
---|---|---|---|---|
fmed-11-1465802.pdf | 805,42 kB | Adobe PDF | Öffnen/Anzeigen |
Titel: | A single center retrospective study on real world CAR T-cell therapy: focus on early hematological toxicity |
VerfasserIn: | Lesan, Vadim Christofyllakis, Konstantinos ![]() Bewarder, Moritz Thurner, Lorenz Bittenbring, Jörg |
Sprache: | Englisch |
In: | |
Titel: | Frontiers in Medicine |
Bandnummer: | 11 |
Verlag/Plattform: | Frontiers |
Erscheinungsjahr: | 2024 |
Freie Schlagwörter: | lymphoma CAR-T hematological toxicity Hematotox-Score early toxicity |
DDC-Sachgruppe: | 610 Medizin, Gesundheit |
Dokumenttyp: | Journalartikel / Zeitschriftenartikel |
Abstract: | Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and multiple myeloma have poor outcomes. CAR-T completely changed the landscape of therapy options, improving not only response rates but also survival outcomes. Hematological toxicity after chimeric antigen receptor therapy (CAR-T) is of increasing interest, being a recognized prognostic factor in this setting. We report our experience with early hematological toxicity after CAR-T therapy and point some important aspects regarding the Hematotox-Score. We identified a strong negative correlation between Hematotox-Score and platelet count at first day of cytokine release syndrome (CRS). Hematotox-Score was predictive of hemoglobin levels at day 28 after CAR-T. Ferritin remained high after 28 days post CAR-T in patients with high Hematotox-Score. Hematotox-Score did not associate with mortality in our cohort. We did not find any significant association between the hematological parameters (hemoglobin, platelets, and neutrophil counts), ferritin, LDH at first day of CRS and mortality. In conclusion, we demonstrate that HematotoxScore is predictive of early hematological toxicity after CAR-T. Although, patients with higher degree of hematological toxicities have poorer survival outcomes, Hematotox-Score lacks predictive potential, probably due to its limitations. Further development of hematological scores predicting survival outcome in the context of CAR-T are needed. |
DOI der Erstveröffentlichung: | 10.3389/fmed.2024.1465802 |
URL der Erstveröffentlichung: | https://doi.org/10.3389/fmed.2024.1465802 |
Link zu diesem Datensatz: | urn:nbn:de:bsz:291--ds-439876 hdl:20.500.11880/39359 http://dx.doi.org/10.22028/D291-43987 |
ISSN: | 2296-858X |
Datum des Eintrags: | 13-Jan-2025 |
Fakultät: | M - Medizinische Fakultät |
Fachrichtung: | M - Innere Medizin |
Professur: | M - Prof. Dr. Stephan Stilgenbauer M - Dr. med. Lorenz Thurner |
Sammlung: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons